WebNov 1, 1997 · Cisplatin is one of the most widely used agents in cancer treatment. Cisplatin regimens can lead to a more or less pronounced hyponatremia in 4 to 10% of … WebMay 22, 2012 · The development of hyponatremia during cisplatin therapy bears special mention. Cisplatin stimulates AVP secretion to cause SIADH, but it can also directly damage renal tubules to interfere with sodium reabsorption, which in rare cases may lead to hyponatremia via salt wasting nephropathy [ 41 ].
Cisplatin-induced Acute Hyponatremia Leading to A
WebCisplatin is a potent antineoplastic agent derived from platinum and commonly used in the treatment of head and neck, bladder, ovarian, and testicular malignancies. 1,2 Approximately 20% of all cancer patients are prescribed platinum-based chemotherapeutics. 3 Although considered highly effective, cisplatin is also a dose-dependent nephrotoxin, … Webwhich can induce hyponatremia. As regards platinum, cisplatin is more frequently described than carbopla-tin.[1] The incidence of hyponatremia secondary to cisplatin can be as high as 43%,[6] the mechanism of action by which cisplatin induces hyponatremia is 100 105 110 115 120 125 130 135 140 0 100 200 300 400 500 600 Na + urine (ml/H) … hillsborough nc property management
Diagnosis and Management of Hyponatremia in Cancer Patients
WebJul 7, 2024 · 1 Department of Pharmacy, Showa University Hospital, Tokyo, Japan. 2 Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan. 3 Department of Surgery, Division of General and Gastroenterological Surgery, School of Medicine, Showa University, Tokyo, Japan. 4 Showa University Esophageal … WebHyponatremia was defined and graded using the Common Terminology Criteria for Adverse Events, version 4.0, as follows: a serum sodium concentration from lower limit of normal to 130 mEq/L, grade 1; … Webmostly solid tumors had hyponatremia, and of these, 11% had moderate (sodium [Na] 120–129 mEq/L) to severe (Na , 120 mEq/L) hyponatremia (1). This is disproportionately higher than the hyponatremia prevalence rates of 15%–30% reported for general medicine admissions (2). In cancer patients with nonsolid tumors, rates of hyponatremia are less. smart home milano